Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US12168657B2 · kind B2 · utility
2Cited by
62References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2022 |
| Grant date | Dec 17, 2024 |
| Priority date | — |
| Expiry date | Nov 9, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to inhibitors of NLRP3 useful in the treatment of diseases and disorders inhibited by said protein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.